ENTITY
Akeso
Akeso
PulseAugur coverage of Akeso — every cluster mentioning Akeso across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TIMELINE
- 2026-06-01 funding Akeso Bio was among the top net buyers of Southbound Capital, with HK$2.707 billion in net purchases. source
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Akeso's lung cancer drug shows 34% reduced death risk in trials
Akeso's lung cancer drug, ivonescimab, has shown significant promise in phase three clinical trials, reducing the risk of death by 34%. The drug demonstrated a notable survival benefit, with 64.7% of patients alive afte…
-
Southbound Capital Buys HK$4.66B, Akeso Bio Leads Net Purchases
Southbound capital saw a net inflow of HK$4.657 billion, with Akeso Bio, Tencent Holdings, and Pop Mart being the top three net buyers. Akeso Bio specifically received a net purchase of HK$2.707 billion. In contrast, Le…